nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCC2—esophageal cancer	0.356	0.731	CbGaD
Telmisartan—ABCB1—esophageal cancer	0.131	0.269	CbGaD
Telmisartan—SLCO1B3—Methotrexate—esophageal cancer	0.0663	0.177	CbGbCtD
Telmisartan—ABCC2—Carboplatin—esophageal cancer	0.0611	0.163	CbGbCtD
Telmisartan—ABCG2—Carboplatin—esophageal cancer	0.0553	0.147	CbGbCtD
Telmisartan—ABCC2—Cisplatin—esophageal cancer	0.0522	0.139	CbGbCtD
Telmisartan—ABCG2—Cisplatin—esophageal cancer	0.0472	0.126	CbGbCtD
Telmisartan—ABCC2—Methotrexate—esophageal cancer	0.0339	0.0905	CbGbCtD
Telmisartan—ABCG2—Methotrexate—esophageal cancer	0.0307	0.0818	CbGbCtD
Telmisartan—ABCB1—Cisplatin—esophageal cancer	0.017	0.0454	CbGbCtD
Telmisartan—ABCB1—Methotrexate—esophageal cancer	0.0111	0.0295	CbGbCtD
Telmisartan—Olmesartan—ABCC2—esophageal cancer	0.00115	0.486	CrCbGaD
Telmisartan—AGTR1—neck—esophageal cancer	0.000877	0.108	CbGeAlD
Telmisartan—PPARG—neck—esophageal cancer	0.000721	0.0887	CbGeAlD
Telmisartan—Candesartan—PTGS1—esophageal cancer	0.000676	0.286	CrCbGaD
Telmisartan—SLCO1B3—lung—esophageal cancer	0.000625	0.0769	CbGeAlD
Telmisartan—AGTR1—epithelium—esophageal cancer	0.000596	0.0734	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—esophageal cancer	0.000575	0.0707	CbGeAlD
Telmisartan—AGTR1—trachea—esophageal cancer	0.000527	0.0649	CbGeAlD
Telmisartan—PPARG—epithelium—esophageal cancer	0.000491	0.0603	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—esophageal cancer	0.000473	0.0581	CbGeAlD
Telmisartan—AGTR1—lung—esophageal cancer	0.000379	0.0466	CbGeAlD
Telmisartan—PPARG—digestive system—esophageal cancer	0.000373	0.0459	CbGeAlD
Telmisartan—Candesartan—ABCB1—esophageal cancer	0.000329	0.139	CrCbGaD
Telmisartan—ABCC2—digestive system—esophageal cancer	0.000328	0.0404	CbGeAlD
Telmisartan—PPARG—lung—esophageal cancer	0.000312	0.0383	CbGeAlD
Telmisartan—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000293	0.00417	CcSEcCtD
Telmisartan—Arthritis—Capecitabine—esophageal cancer	0.000293	0.00416	CcSEcCtD
Telmisartan—Renal failure—Cisplatin—esophageal cancer	0.000293	0.00415	CcSEcCtD
Telmisartan—Vaginal inflammation—Methotrexate—esophageal cancer	0.000292	0.00415	CcSEcCtD
Telmisartan—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000292	0.00414	CcSEcCtD
Telmisartan—Myocardial infarction—Cisplatin—esophageal cancer	0.000292	0.00414	CcSEcCtD
Telmisartan—Conjunctivitis—Cisplatin—esophageal cancer	0.000289	0.00411	CcSEcCtD
Telmisartan—Cystitis noninfective—Methotrexate—esophageal cancer	0.000285	0.00405	CcSEcCtD
Telmisartan—Melaena—Methotrexate—esophageal cancer	0.000285	0.00405	CcSEcCtD
Telmisartan—Osteoarthritis—Capecitabine—esophageal cancer	0.000285	0.00404	CcSEcCtD
Telmisartan—Pain in extremity—Capecitabine—esophageal cancer	0.000285	0.00404	CcSEcCtD
Telmisartan—Cystitis—Methotrexate—esophageal cancer	0.000282	0.004	CcSEcCtD
Telmisartan—CYP2C19—digestive system—esophageal cancer	0.000282	0.0347	CbGeAlD
Telmisartan—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000282	0.004	CcSEcCtD
Telmisartan—Migraine—Capecitabine—esophageal cancer	0.00028	0.00398	CcSEcCtD
Telmisartan—Vaginal infection—Methotrexate—esophageal cancer	0.000276	0.00391	CcSEcCtD
Telmisartan—Face oedema—Capecitabine—esophageal cancer	0.000275	0.0039	CcSEcCtD
Telmisartan—Bradycardia—Cisplatin—esophageal cancer	0.000272	0.00386	CcSEcCtD
Telmisartan—Blood creatinine increased—Capecitabine—esophageal cancer	0.000267	0.00379	CcSEcCtD
Telmisartan—Bladder pain—Methotrexate—esophageal cancer	0.000264	0.00375	CcSEcCtD
Telmisartan—Urinary tract disorder—Cisplatin—esophageal cancer	0.000264	0.00375	CcSEcCtD
Telmisartan—Connective tissue disorder—Cisplatin—esophageal cancer	0.000263	0.00373	CcSEcCtD
Telmisartan—Urethral disorder—Cisplatin—esophageal cancer	0.000262	0.00372	CcSEcCtD
Telmisartan—Dry skin—Capecitabine—esophageal cancer	0.000261	0.00371	CcSEcCtD
Telmisartan—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00026	0.00369	CcSEcCtD
Telmisartan—AGTR1—lymph node—esophageal cancer	0.000259	0.0319	CbGeAlD
Telmisartan—Hypokalaemia—Capecitabine—esophageal cancer	0.000259	0.00368	CcSEcCtD
Telmisartan—Visual impairment—Cisplatin—esophageal cancer	0.000258	0.00366	CcSEcCtD
Telmisartan—Breast disorder—Capecitabine—esophageal cancer	0.000257	0.00365	CcSEcCtD
Telmisartan—Sepsis—Methotrexate—esophageal cancer	0.000253	0.0036	CcSEcCtD
Telmisartan—Gastritis—Capecitabine—esophageal cancer	0.000252	0.00358	CcSEcCtD
Telmisartan—Muscular weakness—Capecitabine—esophageal cancer	0.000251	0.00357	CcSEcCtD
Telmisartan—Eye disorder—Cisplatin—esophageal cancer	0.00025	0.00355	CcSEcCtD
Telmisartan—Tinnitus—Cisplatin—esophageal cancer	0.000249	0.00354	CcSEcCtD
Telmisartan—Flushing—Cisplatin—esophageal cancer	0.000248	0.00352	CcSEcCtD
Telmisartan—Cardiac disorder—Cisplatin—esophageal cancer	0.000248	0.00352	CcSEcCtD
Telmisartan—Abdominal distension—Capecitabine—esophageal cancer	0.000248	0.00352	CcSEcCtD
Telmisartan—Asthma—Capecitabine—esophageal cancer	0.000246	0.00349	CcSEcCtD
Telmisartan—Diabetes mellitus—Methotrexate—esophageal cancer	0.000244	0.00346	CcSEcCtD
Telmisartan—Bronchospasm—Capecitabine—esophageal cancer	0.000242	0.00344	CcSEcCtD
Telmisartan—Immune system disorder—Cisplatin—esophageal cancer	0.000241	0.00343	CcSEcCtD
Telmisartan—Mediastinal disorder—Cisplatin—esophageal cancer	0.000241	0.00342	CcSEcCtD
Telmisartan—Angina pectoris—Capecitabine—esophageal cancer	0.00024	0.0034	CcSEcCtD
Telmisartan—Sweating increased—Capecitabine—esophageal cancer	0.00024	0.0034	CcSEcCtD
Telmisartan—Arrhythmia—Cisplatin—esophageal cancer	0.000239	0.00339	CcSEcCtD
Telmisartan—Bronchitis—Capecitabine—esophageal cancer	0.000237	0.00336	CcSEcCtD
Telmisartan—Abdominal discomfort—Capecitabine—esophageal cancer	0.000236	0.00335	CcSEcCtD
Telmisartan—Erythema—Cisplatin—esophageal cancer	0.000233	0.0033	CcSEcCtD
Telmisartan—Malnutrition—Cisplatin—esophageal cancer	0.000233	0.0033	CcSEcCtD
Telmisartan—Dysuria—Capecitabine—esophageal cancer	0.00023	0.00327	CcSEcCtD
Telmisartan—Renal failure acute—Methotrexate—esophageal cancer	0.00023	0.00326	CcSEcCtD
Telmisartan—Flatulence—Cisplatin—esophageal cancer	0.000229	0.00325	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000229	0.00325	CcSEcCtD
Telmisartan—Visual disturbance—Methotrexate—esophageal cancer	0.000224	0.00318	CcSEcCtD
Telmisartan—Muscle spasms—Cisplatin—esophageal cancer	0.000224	0.00318	CcSEcCtD
Telmisartan—Pneumonia—Capecitabine—esophageal cancer	0.000221	0.00313	CcSEcCtD
Telmisartan—Infestation NOS—Capecitabine—esophageal cancer	0.000219	0.00312	CcSEcCtD
Telmisartan—Infestation—Capecitabine—esophageal cancer	0.000219	0.00312	CcSEcCtD
Telmisartan—Depression—Capecitabine—esophageal cancer	0.000219	0.00311	CcSEcCtD
Telmisartan—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000216	0.00307	CcSEcCtD
Telmisartan—Ill-defined disorder—Cisplatin—esophageal cancer	0.000216	0.00306	CcSEcCtD
Telmisartan—Renal failure—Capecitabine—esophageal cancer	0.000216	0.00306	CcSEcCtD
Telmisartan—Myocardial infarction—Capecitabine—esophageal cancer	0.000215	0.00305	CcSEcCtD
Telmisartan—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000215	0.00305	CcSEcCtD
Telmisartan—Anaemia—Cisplatin—esophageal cancer	0.000215	0.00305	CcSEcCtD
Telmisartan—Urinary tract infection—Capecitabine—esophageal cancer	0.000213	0.00303	CcSEcCtD
Telmisartan—Conjunctivitis—Capecitabine—esophageal cancer	0.000213	0.00303	CcSEcCtD
Telmisartan—PPARG—lymph node—esophageal cancer	0.000213	0.0262	CbGeAlD
Telmisartan—Osteoarthritis—Methotrexate—esophageal cancer	0.000212	0.00301	CcSEcCtD
Telmisartan—Losartan—ABCB1—esophageal cancer	0.000212	0.0895	CrCbGaD
Telmisartan—Malaise—Cisplatin—esophageal cancer	0.00021	0.00298	CcSEcCtD
Telmisartan—Haematuria—Capecitabine—esophageal cancer	0.000209	0.00297	CcSEcCtD
Telmisartan—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000208	0.00295	CcSEcCtD
Telmisartan—Epistaxis—Capecitabine—esophageal cancer	0.000207	0.00294	CcSEcCtD
Telmisartan—Bradycardia—Capecitabine—esophageal cancer	0.000201	0.00285	CcSEcCtD
Telmisartan—ABCG2—lung—esophageal cancer	0.0002	0.0246	CbGeAlD
Telmisartan—Myalgia—Cisplatin—esophageal cancer	0.000198	0.00281	CcSEcCtD
Telmisartan—Rhinitis—Capecitabine—esophageal cancer	0.000198	0.0028	CcSEcCtD
Telmisartan—Anxiety—Cisplatin—esophageal cancer	0.000197	0.0028	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000197	0.00279	CcSEcCtD
Telmisartan—Hypoaesthesia—Capecitabine—esophageal cancer	0.000196	0.00278	CcSEcCtD
Telmisartan—Discomfort—Cisplatin—esophageal cancer	0.000196	0.00278	CcSEcCtD
Telmisartan—Pharyngitis—Capecitabine—esophageal cancer	0.000196	0.00278	CcSEcCtD
Telmisartan—Urinary tract disorder—Capecitabine—esophageal cancer	0.000195	0.00276	CcSEcCtD
Telmisartan—Oedema peripheral—Capecitabine—esophageal cancer	0.000194	0.00276	CcSEcCtD
Telmisartan—Connective tissue disorder—Capecitabine—esophageal cancer	0.000194	0.00275	CcSEcCtD
Telmisartan—Urethral disorder—Capecitabine—esophageal cancer	0.000193	0.00274	CcSEcCtD
Telmisartan—Breast disorder—Methotrexate—esophageal cancer	0.000192	0.00272	CcSEcCtD
Telmisartan—Oedema—Cisplatin—esophageal cancer	0.00019	0.0027	CcSEcCtD
Telmisartan—Anaphylactic shock—Cisplatin—esophageal cancer	0.00019	0.0027	CcSEcCtD
Telmisartan—Visual impairment—Capecitabine—esophageal cancer	0.00019	0.0027	CcSEcCtD
Telmisartan—Infection—Cisplatin—esophageal cancer	0.000189	0.00268	CcSEcCtD
Telmisartan—ABCC2—lymph node—esophageal cancer	0.000187	0.0231	CbGeAlD
Telmisartan—Nervous system disorder—Cisplatin—esophageal cancer	0.000186	0.00264	CcSEcCtD
Telmisartan—Thrombocytopenia—Cisplatin—esophageal cancer	0.000186	0.00264	CcSEcCtD
Telmisartan—Tachycardia—Cisplatin—esophageal cancer	0.000185	0.00263	CcSEcCtD
Telmisartan—Skin disorder—Cisplatin—esophageal cancer	0.000184	0.00262	CcSEcCtD
Telmisartan—Eye disorder—Capecitabine—esophageal cancer	0.000184	0.00261	CcSEcCtD
Telmisartan—Tinnitus—Capecitabine—esophageal cancer	0.000184	0.00261	CcSEcCtD
Telmisartan—Hyperhidrosis—Cisplatin—esophageal cancer	0.000184	0.00261	CcSEcCtD
Telmisartan—Asthma—Methotrexate—esophageal cancer	0.000183	0.0026	CcSEcCtD
Telmisartan—Flushing—Capecitabine—esophageal cancer	0.000183	0.0026	CcSEcCtD
Telmisartan—Cardiac disorder—Capecitabine—esophageal cancer	0.000183	0.0026	CcSEcCtD
Telmisartan—Eosinophilia—Methotrexate—esophageal cancer	0.000181	0.00258	CcSEcCtD
Telmisartan—Anorexia—Cisplatin—esophageal cancer	0.000181	0.00257	CcSEcCtD
Telmisartan—Angiopathy—Capecitabine—esophageal cancer	0.000179	0.00254	CcSEcCtD
Telmisartan—Immune system disorder—Capecitabine—esophageal cancer	0.000178	0.00253	CcSEcCtD
Telmisartan—Mediastinal disorder—Capecitabine—esophageal cancer	0.000178	0.00252	CcSEcCtD
Telmisartan—Hypotension—Cisplatin—esophageal cancer	0.000177	0.00252	CcSEcCtD
Telmisartan—Chills—Capecitabine—esophageal cancer	0.000177	0.00251	CcSEcCtD
Telmisartan—Arrhythmia—Capecitabine—esophageal cancer	0.000176	0.0025	CcSEcCtD
Telmisartan—Abdominal discomfort—Methotrexate—esophageal cancer	0.000176	0.00249	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000173	0.00246	CcSEcCtD
Telmisartan—Mental disorder—Capecitabine—esophageal cancer	0.000173	0.00245	CcSEcCtD
Telmisartan—Malnutrition—Capecitabine—esophageal cancer	0.000171	0.00243	CcSEcCtD
Telmisartan—Erythema—Capecitabine—esophageal cancer	0.000171	0.00243	CcSEcCtD
Telmisartan—Dysuria—Methotrexate—esophageal cancer	0.000171	0.00243	CcSEcCtD
Telmisartan—Paraesthesia—Cisplatin—esophageal cancer	0.00017	0.00242	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00017	0.00242	CcSEcCtD
Telmisartan—Dyspnoea—Cisplatin—esophageal cancer	0.000169	0.0024	CcSEcCtD
Telmisartan—Flatulence—Capecitabine—esophageal cancer	0.000169	0.0024	CcSEcCtD
Telmisartan—Erectile dysfunction—Methotrexate—esophageal cancer	0.000169	0.0024	CcSEcCtD
Telmisartan—Dysgeusia—Capecitabine—esophageal cancer	0.000168	0.00238	CcSEcCtD
Telmisartan—Back pain—Capecitabine—esophageal cancer	0.000166	0.00236	CcSEcCtD
Telmisartan—Decreased appetite—Cisplatin—esophageal cancer	0.000165	0.00234	CcSEcCtD
Telmisartan—Muscle spasms—Capecitabine—esophageal cancer	0.000165	0.00234	CcSEcCtD
Telmisartan—Pneumonia—Methotrexate—esophageal cancer	0.000164	0.00233	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000164	0.00233	CcSEcCtD
Telmisartan—Infestation—Methotrexate—esophageal cancer	0.000163	0.00232	CcSEcCtD
Telmisartan—Infestation NOS—Methotrexate—esophageal cancer	0.000163	0.00232	CcSEcCtD
Telmisartan—Depression—Methotrexate—esophageal cancer	0.000163	0.00231	CcSEcCtD
Telmisartan—Pain—Cisplatin—esophageal cancer	0.000162	0.00231	CcSEcCtD
Telmisartan—Renal failure—Methotrexate—esophageal cancer	0.000161	0.00228	CcSEcCtD
Telmisartan—Ill-defined disorder—Capecitabine—esophageal cancer	0.000159	0.00226	CcSEcCtD
Telmisartan—Conjunctivitis—Methotrexate—esophageal cancer	0.000159	0.00225	CcSEcCtD
Telmisartan—Anaemia—Capecitabine—esophageal cancer	0.000159	0.00225	CcSEcCtD
Telmisartan—Feeling abnormal—Cisplatin—esophageal cancer	0.000156	0.00222	CcSEcCtD
Telmisartan—Haematuria—Methotrexate—esophageal cancer	0.000156	0.00221	CcSEcCtD
Telmisartan—ABCB1—epithelium—esophageal cancer	0.000155	0.0191	CbGeAlD
Telmisartan—Malaise—Capecitabine—esophageal cancer	0.000155	0.0022	CcSEcCtD
Telmisartan—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000155	0.00219	CcSEcCtD
Telmisartan—Epistaxis—Methotrexate—esophageal cancer	0.000154	0.00219	CcSEcCtD
Telmisartan—Vertigo—Capecitabine—esophageal cancer	0.000154	0.00219	CcSEcCtD
Telmisartan—Syncope—Capecitabine—esophageal cancer	0.000154	0.00218	CcSEcCtD
Telmisartan—Palpitations—Capecitabine—esophageal cancer	0.000152	0.00215	CcSEcCtD
Telmisartan—Loss of consciousness—Capecitabine—esophageal cancer	0.000151	0.00214	CcSEcCtD
Telmisartan—Body temperature increased—Cisplatin—esophageal cancer	0.00015	0.00213	CcSEcCtD
Telmisartan—Cough—Capecitabine—esophageal cancer	0.00015	0.00212	CcSEcCtD
Telmisartan—Hypertension—Capecitabine—esophageal cancer	0.000148	0.0021	CcSEcCtD
Telmisartan—Chest pain—Capecitabine—esophageal cancer	0.000146	0.00207	CcSEcCtD
Telmisartan—Myalgia—Capecitabine—esophageal cancer	0.000146	0.00207	CcSEcCtD
Telmisartan—Arthralgia—Capecitabine—esophageal cancer	0.000146	0.00207	CcSEcCtD
Telmisartan—Pharyngitis—Methotrexate—esophageal cancer	0.000146	0.00207	CcSEcCtD
Telmisartan—Anxiety—Capecitabine—esophageal cancer	0.000146	0.00207	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000145	0.00206	CcSEcCtD
Telmisartan—Urinary tract disorder—Methotrexate—esophageal cancer	0.000145	0.00206	CcSEcCtD
Telmisartan—Discomfort—Capecitabine—esophageal cancer	0.000144	0.00205	CcSEcCtD
Telmisartan—Urethral disorder—Methotrexate—esophageal cancer	0.000144	0.00204	CcSEcCtD
Telmisartan—Dry mouth—Capecitabine—esophageal cancer	0.000143	0.00203	CcSEcCtD
Telmisartan—Visual impairment—Methotrexate—esophageal cancer	0.000141	0.00201	CcSEcCtD
Telmisartan—Oedema—Capecitabine—esophageal cancer	0.00014	0.00199	CcSEcCtD
Telmisartan—Hypersensitivity—Cisplatin—esophageal cancer	0.00014	0.00199	CcSEcCtD
Telmisartan—Infection—Capecitabine—esophageal cancer	0.000139	0.00197	CcSEcCtD
Telmisartan—Shock—Capecitabine—esophageal cancer	0.000138	0.00195	CcSEcCtD
Telmisartan—Nervous system disorder—Capecitabine—esophageal cancer	0.000137	0.00195	CcSEcCtD
Telmisartan—ABCB1—trachea—esophageal cancer	0.000137	0.0169	CbGeAlD
Telmisartan—Eye disorder—Methotrexate—esophageal cancer	0.000137	0.00195	CcSEcCtD
Telmisartan—Thrombocytopenia—Capecitabine—esophageal cancer	0.000137	0.00195	CcSEcCtD
Telmisartan—Tinnitus—Methotrexate—esophageal cancer	0.000137	0.00194	CcSEcCtD
Telmisartan—ABCG2—lymph node—esophageal cancer	0.000137	0.0168	CbGeAlD
Telmisartan—Tachycardia—Capecitabine—esophageal cancer	0.000137	0.00194	CcSEcCtD
Telmisartan—Asthenia—Cisplatin—esophageal cancer	0.000136	0.00193	CcSEcCtD
Telmisartan—Cardiac disorder—Methotrexate—esophageal cancer	0.000136	0.00193	CcSEcCtD
Telmisartan—Skin disorder—Capecitabine—esophageal cancer	0.000136	0.00193	CcSEcCtD
Telmisartan—Hyperhidrosis—Capecitabine—esophageal cancer	0.000135	0.00192	CcSEcCtD
Telmisartan—Anorexia—Capecitabine—esophageal cancer	0.000133	0.00189	CcSEcCtD
Telmisartan—Angiopathy—Methotrexate—esophageal cancer	0.000133	0.00189	CcSEcCtD
Telmisartan—Immune system disorder—Methotrexate—esophageal cancer	0.000132	0.00188	CcSEcCtD
Telmisartan—Mediastinal disorder—Methotrexate—esophageal cancer	0.000132	0.00188	CcSEcCtD
Telmisartan—Chills—Methotrexate—esophageal cancer	0.000132	0.00187	CcSEcCtD
Telmisartan—Hypotension—Capecitabine—esophageal cancer	0.000131	0.00186	CcSEcCtD
Telmisartan—Diarrhoea—Cisplatin—esophageal cancer	0.00013	0.00184	CcSEcCtD
Telmisartan—Mental disorder—Methotrexate—esophageal cancer	0.000128	0.00182	CcSEcCtD
Telmisartan—Malnutrition—Methotrexate—esophageal cancer	0.000128	0.00181	CcSEcCtD
Telmisartan—Erythema—Methotrexate—esophageal cancer	0.000128	0.00181	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000128	0.00181	CcSEcCtD
Telmisartan—Insomnia—Capecitabine—esophageal cancer	0.000127	0.0018	CcSEcCtD
Telmisartan—Paraesthesia—Capecitabine—esophageal cancer	0.000126	0.00178	CcSEcCtD
Telmisartan—Dysgeusia—Methotrexate—esophageal cancer	0.000125	0.00177	CcSEcCtD
Telmisartan—Dyspnoea—Capecitabine—esophageal cancer	0.000125	0.00177	CcSEcCtD
Telmisartan—Back pain—Methotrexate—esophageal cancer	0.000123	0.00175	CcSEcCtD
Telmisartan—Dyspepsia—Capecitabine—esophageal cancer	0.000123	0.00175	CcSEcCtD
Telmisartan—Decreased appetite—Capecitabine—esophageal cancer	0.000122	0.00173	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000121	0.00172	CcSEcCtD
Telmisartan—Vomiting—Cisplatin—esophageal cancer	0.000121	0.00171	CcSEcCtD
Telmisartan—Fatigue—Capecitabine—esophageal cancer	0.000121	0.00171	CcSEcCtD
Telmisartan—Rash—Cisplatin—esophageal cancer	0.00012	0.0017	CcSEcCtD
Telmisartan—Pain—Capecitabine—esophageal cancer	0.00012	0.0017	CcSEcCtD
Telmisartan—Constipation—Capecitabine—esophageal cancer	0.00012	0.0017	CcSEcCtD
Telmisartan—Dermatitis—Cisplatin—esophageal cancer	0.00012	0.0017	CcSEcCtD
Telmisartan—Ill-defined disorder—Methotrexate—esophageal cancer	0.000118	0.00168	CcSEcCtD
Telmisartan—Anaemia—Methotrexate—esophageal cancer	0.000118	0.00168	CcSEcCtD
Telmisartan—ABCB1—digestive system—esophageal cancer	0.000118	0.0145	CbGeAlD
Telmisartan—Feeling abnormal—Capecitabine—esophageal cancer	0.000115	0.00164	CcSEcCtD
Telmisartan—Malaise—Methotrexate—esophageal cancer	0.000115	0.00163	CcSEcCtD
Telmisartan—Vertigo—Methotrexate—esophageal cancer	0.000115	0.00163	CcSEcCtD
Telmisartan—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000114	0.00162	CcSEcCtD
Telmisartan—Nausea—Cisplatin—esophageal cancer	0.000113	0.0016	CcSEcCtD
Telmisartan—Cough—Methotrexate—esophageal cancer	0.000111	0.00158	CcSEcCtD
Telmisartan—Urticaria—Capecitabine—esophageal cancer	0.000111	0.00158	CcSEcCtD
Telmisartan—Abdominal pain—Capecitabine—esophageal cancer	0.000111	0.00157	CcSEcCtD
Telmisartan—Body temperature increased—Capecitabine—esophageal cancer	0.000111	0.00157	CcSEcCtD
Telmisartan—Myalgia—Methotrexate—esophageal cancer	0.000109	0.00154	CcSEcCtD
Telmisartan—Arthralgia—Methotrexate—esophageal cancer	0.000109	0.00154	CcSEcCtD
Telmisartan—Chest pain—Methotrexate—esophageal cancer	0.000109	0.00154	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000108	0.00153	CcSEcCtD
Telmisartan—Discomfort—Methotrexate—esophageal cancer	0.000107	0.00152	CcSEcCtD
Telmisartan—Anaphylactic shock—Methotrexate—esophageal cancer	0.000104	0.00148	CcSEcCtD
Telmisartan—Infection—Methotrexate—esophageal cancer	0.000104	0.00147	CcSEcCtD
Telmisartan—Hypersensitivity—Capecitabine—esophageal cancer	0.000103	0.00146	CcSEcCtD
Telmisartan—Nervous system disorder—Methotrexate—esophageal cancer	0.000102	0.00145	CcSEcCtD
Telmisartan—Thrombocytopenia—Methotrexate—esophageal cancer	0.000102	0.00145	CcSEcCtD
Telmisartan—Skin disorder—Methotrexate—esophageal cancer	0.000101	0.00144	CcSEcCtD
Telmisartan—Hyperhidrosis—Methotrexate—esophageal cancer	0.000101	0.00143	CcSEcCtD
Telmisartan—Asthenia—Capecitabine—esophageal cancer	0.0001	0.00143	CcSEcCtD
Telmisartan—Anorexia—Methotrexate—esophageal cancer	9.93e-05	0.00141	CcSEcCtD
Telmisartan—Pruritus—Capecitabine—esophageal cancer	9.9e-05	0.00141	CcSEcCtD
Telmisartan—ABCB1—lung—esophageal cancer	9.85e-05	0.0121	CbGeAlD
Telmisartan—Hypotension—Methotrexate—esophageal cancer	9.74e-05	0.00138	CcSEcCtD
Telmisartan—Diarrhoea—Capecitabine—esophageal cancer	9.58e-05	0.00136	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.49e-05	0.00135	CcSEcCtD
Telmisartan—Insomnia—Methotrexate—esophageal cancer	9.42e-05	0.00134	CcSEcCtD
Telmisartan—Paraesthesia—Methotrexate—esophageal cancer	9.36e-05	0.00133	CcSEcCtD
Telmisartan—Dyspnoea—Methotrexate—esophageal cancer	9.29e-05	0.00132	CcSEcCtD
Telmisartan—Somnolence—Methotrexate—esophageal cancer	9.26e-05	0.00132	CcSEcCtD
Telmisartan—Dizziness—Capecitabine—esophageal cancer	9.26e-05	0.00131	CcSEcCtD
Telmisartan—Dyspepsia—Methotrexate—esophageal cancer	9.17e-05	0.0013	CcSEcCtD
Telmisartan—Decreased appetite—Methotrexate—esophageal cancer	9.06e-05	0.00129	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Methotrexate—esophageal cancer	9e-05	0.00128	CcSEcCtD
Telmisartan—Fatigue—Methotrexate—esophageal cancer	8.98e-05	0.00128	CcSEcCtD
Telmisartan—Pain—Methotrexate—esophageal cancer	8.91e-05	0.00126	CcSEcCtD
Telmisartan—Vomiting—Capecitabine—esophageal cancer	8.9e-05	0.00126	CcSEcCtD
Telmisartan—Rash—Capecitabine—esophageal cancer	8.83e-05	0.00125	CcSEcCtD
Telmisartan—Dermatitis—Capecitabine—esophageal cancer	8.82e-05	0.00125	CcSEcCtD
Telmisartan—Headache—Capecitabine—esophageal cancer	8.77e-05	0.00124	CcSEcCtD
Telmisartan—Feeling abnormal—Methotrexate—esophageal cancer	8.59e-05	0.00122	CcSEcCtD
Telmisartan—Gastrointestinal pain—Methotrexate—esophageal cancer	8.52e-05	0.00121	CcSEcCtD
Telmisartan—Nausea—Capecitabine—esophageal cancer	8.31e-05	0.00118	CcSEcCtD
Telmisartan—Urticaria—Methotrexate—esophageal cancer	8.28e-05	0.00118	CcSEcCtD
Telmisartan—Abdominal pain—Methotrexate—esophageal cancer	8.24e-05	0.00117	CcSEcCtD
Telmisartan—Body temperature increased—Methotrexate—esophageal cancer	8.24e-05	0.00117	CcSEcCtD
Telmisartan—Hypersensitivity—Methotrexate—esophageal cancer	7.68e-05	0.00109	CcSEcCtD
Telmisartan—Asthenia—Methotrexate—esophageal cancer	7.48e-05	0.00106	CcSEcCtD
Telmisartan—Pruritus—Methotrexate—esophageal cancer	7.37e-05	0.00105	CcSEcCtD
Telmisartan—Diarrhoea—Methotrexate—esophageal cancer	7.13e-05	0.00101	CcSEcCtD
Telmisartan—Dizziness—Methotrexate—esophageal cancer	6.89e-05	0.000978	CcSEcCtD
Telmisartan—ABCB1—lymph node—esophageal cancer	6.74e-05	0.00829	CbGeAlD
Telmisartan—Vomiting—Methotrexate—esophageal cancer	6.62e-05	0.00094	CcSEcCtD
Telmisartan—Rash—Methotrexate—esophageal cancer	6.57e-05	0.000933	CcSEcCtD
Telmisartan—Dermatitis—Methotrexate—esophageal cancer	6.56e-05	0.000932	CcSEcCtD
Telmisartan—Headache—Methotrexate—esophageal cancer	6.53e-05	0.000927	CcSEcCtD
Telmisartan—Nausea—Methotrexate—esophageal cancer	6.19e-05	0.000879	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—ALOX15—esophageal cancer	4.12e-05	0.000723	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	4.12e-05	0.000722	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—EP300—esophageal cancer	4.01e-05	0.000703	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HIST1H2BM—esophageal cancer	3.98e-05	0.000698	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TPI1—esophageal cancer	3.93e-05	0.000689	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTO1—esophageal cancer	3.93e-05	0.000689	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	3.91e-05	0.000685	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ADH1B—esophageal cancer	3.88e-05	0.000681	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ELMO1—esophageal cancer	3.86e-05	0.000676	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	3.85e-05	0.000676	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA1—esophageal cancer	3.8e-05	0.000666	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC10A2—esophageal cancer	3.8e-05	0.000666	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	3.78e-05	0.000662	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALDOB—esophageal cancer	3.77e-05	0.000661	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKAP13—esophageal cancer	3.77e-05	0.000661	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	3.74e-05	0.000655	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	3.73e-05	0.000653	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TYMP—esophageal cancer	3.71e-05	0.00065	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GAPDH—esophageal cancer	3.63e-05	0.000636	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	3.62e-05	0.000634	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP26A1—esophageal cancer	3.61e-05	0.000633	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CRABP1—esophageal cancer	3.6e-05	0.00063	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	3.57e-05	0.000626	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	3.57e-05	0.000626	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALOX15—esophageal cancer	3.52e-05	0.000617	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIST1H2BM—esophageal cancer	3.48e-05	0.00061	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA2—esophageal cancer	3.47e-05	0.000609	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDE4D—esophageal cancer	3.45e-05	0.000604	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	3.42e-05	0.0006	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GNG7—esophageal cancer	3.42e-05	0.0006	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—NOTCH1—esophageal cancer	3.36e-05	0.000589	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KDR—esophageal cancer	3.36e-05	0.000589	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TPI1—esophageal cancer	3.36e-05	0.000588	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTO1—esophageal cancer	3.36e-05	0.000588	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—esophageal cancer	3.29e-05	0.000576	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GNG7—esophageal cancer	3.28e-05	0.000575	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLCE1—esophageal cancer	3.23e-05	0.000566	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADH7—esophageal cancer	3.23e-05	0.000566	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALDOB—esophageal cancer	3.22e-05	0.000564	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALDH2—esophageal cancer	3.21e-05	0.000562	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	3.19e-05	0.000559	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.18e-05	0.000558	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—NOTCH1—esophageal cancer	3.16e-05	0.000555	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GAPDH—esophageal cancer	3.1e-05	0.000543	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PSME1—esophageal cancer	3.09e-05	0.000542	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PSME2—esophageal cancer	3.09e-05	0.000542	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—XIAP—esophageal cancer	3.07e-05	0.000539	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CRABP1—esophageal cancer	3.07e-05	0.000538	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.06e-05	0.000536	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTT1—esophageal cancer	3.05e-05	0.000535	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CREBBP—esophageal cancer	3.05e-05	0.000534	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP2A6—esophageal cancer	3.01e-05	0.000528	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3e-05	0.000526	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GNG7—esophageal cancer	2.92e-05	0.000512	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH3—esophageal cancer	2.92e-05	0.000511	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNA1—esophageal cancer	2.91e-05	0.000509	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL2—esophageal cancer	2.89e-05	0.000506	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—esophageal cancer	2.87e-05	0.000503	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CREBBP—esophageal cancer	2.87e-05	0.000503	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ENO1—esophageal cancer	2.86e-05	0.000501	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS1—esophageal cancer	2.86e-05	0.000501	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.86e-05	0.0005	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADH1B—esophageal cancer	2.83e-05	0.000496	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PSME1—esophageal cancer	2.82e-05	0.000494	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PSME2—esophageal cancer	2.82e-05	0.000494	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	2.78e-05	0.000488	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.77e-05	0.000485	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALDH2—esophageal cancer	2.74e-05	0.000479	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.71e-05	0.000475	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TYMP—esophageal cancer	2.71e-05	0.000474	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSME2—esophageal cancer	2.7e-05	0.000473	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSME1—esophageal cancer	2.7e-05	0.000473	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ANXA1—esophageal cancer	2.69e-05	0.000471	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	2.66e-05	0.000466	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP26A1—esophageal cancer	2.63e-05	0.000461	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH2—esophageal cancer	2.61e-05	0.000458	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SST—esophageal cancer	2.61e-05	0.000458	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTT1—esophageal cancer	2.6e-05	0.000456	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP2A6—esophageal cancer	2.57e-05	0.000451	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALOX15—esophageal cancer	2.56e-05	0.00045	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.56e-05	0.000449	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GHRL—esophageal cancer	2.55e-05	0.000446	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH3—esophageal cancer	2.55e-05	0.000446	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FBXW7—esophageal cancer	2.5e-05	0.000439	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BLVRB—esophageal cancer	2.47e-05	0.000434	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC52A3—esophageal cancer	2.47e-05	0.000434	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.46e-05	0.000431	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.46e-05	0.000431	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTO1—esophageal cancer	2.45e-05	0.000429	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TPI1—esophageal cancer	2.45e-05	0.000429	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ENO1—esophageal cancer	2.44e-05	0.000427	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS1—esophageal cancer	2.44e-05	0.000427	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1B1—esophageal cancer	2.43e-05	0.000426	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.43e-05	0.000426	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.42e-05	0.000424	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.41e-05	0.000423	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BLVRB—esophageal cancer	2.41e-05	0.000423	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSME2—esophageal cancer	2.4e-05	0.000421	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSME1—esophageal cancer	2.4e-05	0.000421	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—esophageal cancer	2.4e-05	0.000421	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALDOB—esophageal cancer	2.35e-05	0.000411	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP19A1—esophageal cancer	2.28e-05	0.0004	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH2—esophageal cancer	2.28e-05	0.0004	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GAPDH—esophageal cancer	2.26e-05	0.000396	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CRABP1—esophageal cancer	2.24e-05	0.000392	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.21e-05	0.000388	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SMAD4—esophageal cancer	2.2e-05	0.000385	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GNG7—esophageal cancer	2.13e-05	0.000373	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC10A2—esophageal cancer	2.1e-05	0.000369	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA1—esophageal cancer	2.1e-05	0.000369	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.1e-05	0.000368	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.08e-05	0.000365	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HMOX1—esophageal cancer	2.08e-05	0.000365	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1B1—esophageal cancer	2.07e-05	0.000363	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA1—esophageal cancer	2.05e-05	0.00036	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.05e-05	0.00036	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.05e-05	0.000358	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.04e-05	0.000358	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFBR2—esophageal cancer	2.03e-05	0.000355	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.03e-05	0.000355	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—esophageal cancer	2e-05	0.000351	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALDH2—esophageal cancer	1.99e-05	0.00035	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	1.98e-05	0.000347	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EP300—esophageal cancer	1.95e-05	0.000342	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP19A1—esophageal cancer	1.95e-05	0.000342	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA2—esophageal cancer	1.92e-05	0.000337	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SMAD4—esophageal cancer	1.92e-05	0.000336	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTT1—esophageal cancer	1.9e-05	0.000333	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	1.88e-05	0.00033	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA2—esophageal cancer	1.88e-05	0.000329	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2A6—esophageal cancer	1.88e-05	0.000329	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—esophageal cancer	1.81e-05	0.000317	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.79e-05	0.000314	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLCE1—esophageal cancer	1.79e-05	0.000313	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADH7—esophageal cancer	1.79e-05	0.000313	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HMOX1—esophageal cancer	1.78e-05	0.000312	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ENO1—esophageal cancer	1.78e-05	0.000312	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS1—esophageal cancer	1.78e-05	0.000312	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.78e-05	0.000311	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.77e-05	0.00031	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSME2—esophageal cancer	1.75e-05	0.000307	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSME1—esophageal cancer	1.75e-05	0.000307	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADH7—esophageal cancer	1.75e-05	0.000306	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLCE1—esophageal cancer	1.75e-05	0.000306	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.74e-05	0.000306	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.73e-05	0.000303	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—esophageal cancer	1.71e-05	0.000299	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—esophageal cancer	1.67e-05	0.000292	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.65e-05	0.000289	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NOTCH1—esophageal cancer	1.62e-05	0.000284	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—esophageal cancer	1.57e-05	0.000275	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADH1B—esophageal cancer	1.57e-05	0.000275	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADH1B—esophageal cancer	1.53e-05	0.000268	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.51e-05	0.000265	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1B1—esophageal cancer	1.51e-05	0.000265	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—esophageal cancer	1.5e-05	0.000263	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TYMP—esophageal cancer	1.5e-05	0.000263	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.5e-05	0.000262	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CREBBP—esophageal cancer	1.47e-05	0.000257	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TYMP—esophageal cancer	1.46e-05	0.000256	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP26A1—esophageal cancer	1.46e-05	0.000256	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.44e-05	0.000252	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.42e-05	0.000249	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP19A1—esophageal cancer	1.42e-05	0.000249	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALOX15—esophageal cancer	1.42e-05	0.000249	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOTCH1—esophageal cancer	1.41e-05	0.000248	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.4e-05	0.000246	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALOX15—esophageal cancer	1.39e-05	0.000243	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.36e-05	0.000238	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TPI1—esophageal cancer	1.36e-05	0.000238	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CREBBP—esophageal cancer	1.34e-05	0.000234	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTO1—esophageal cancer	1.32e-05	0.000232	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TPI1—esophageal cancer	1.32e-05	0.000232	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.3e-05	0.000228	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—esophageal cancer	1.3e-05	0.000227	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.29e-05	0.000226	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CREBBP—esophageal cancer	1.28e-05	0.000225	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDOB—esophageal cancer	1.27e-05	0.000222	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—esophageal cancer	1.26e-05	0.000221	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.25e-05	0.000219	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—esophageal cancer	1.24e-05	0.000218	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.24e-05	0.000217	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GAPDH—esophageal cancer	1.22e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.22e-05	0.000214	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CRABP1—esophageal cancer	1.21e-05	0.000212	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.2e-05	0.000211	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—esophageal cancer	1.2e-05	0.00021	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GNG7—esophageal cancer	1.18e-05	0.000207	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.18e-05	0.000207	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GNG7—esophageal cancer	1.15e-05	0.000202	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—esophageal cancer	1.15e-05	0.000201	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CREBBP—esophageal cancer	1.14e-05	0.0002	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.1e-05	0.000194	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—esophageal cancer	1.1e-05	0.000192	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—esophageal cancer	1.09e-05	0.000192	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDH2—esophageal cancer	1.08e-05	0.000189	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—esophageal cancer	1.07e-05	0.000188	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.05e-05	0.000184	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.04e-05	0.000182	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.03e-05	0.000181	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—esophageal cancer	1.03e-05	0.00018	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—esophageal cancer	1.02e-05	0.000179	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.01e-05	0.000178	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ENO1—esophageal cancer	9.85e-06	0.000173	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS1—esophageal cancer	9.85e-06	0.000173	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSME2—esophageal cancer	9.7e-06	0.00017	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSME1—esophageal cancer	9.7e-06	0.00017	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ENO1—esophageal cancer	9.61e-06	0.000168	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS1—esophageal cancer	9.61e-06	0.000168	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	9.6e-06	0.000168	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—esophageal cancer	9.48e-06	0.000166	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSME2—esophageal cancer	9.47e-06	0.000166	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSME1—esophageal cancer	9.47e-06	0.000166	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—esophageal cancer	9.34e-06	0.000164	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1A—esophageal cancer	9.17e-06	0.000161	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—EP300—esophageal cancer	9.11e-06	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EP300—esophageal cancer	8.73e-06	0.000153	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—esophageal cancer	8.71e-06	0.000153	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.47e-06	0.000149	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1B1—esophageal cancer	8.37e-06	0.000147	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CREBBP—esophageal cancer	8.32e-06	0.000146	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1B1—esophageal cancer	8.17e-06	0.000143	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP19A1—esophageal cancer	7.87e-06	0.000138	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—EP300—esophageal cancer	7.77e-06	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP19A1—esophageal cancer	7.68e-06	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—esophageal cancer	7.61e-06	0.000133	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—esophageal cancer	7.45e-06	0.000131	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—esophageal cancer	7.44e-06	0.00013	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—esophageal cancer	7.18e-06	0.000126	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.05e-06	0.000124	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—esophageal cancer	7.01e-06	0.000123	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—esophageal cancer	6.9e-06	0.000121	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—esophageal cancer	6.81e-06	0.000119	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	6.74e-06	0.000118	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—esophageal cancer	6.46e-06	0.000113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—esophageal cancer	6.25e-06	0.000109	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—esophageal cancer	5.75e-06	0.000101	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—EP300—esophageal cancer	5.67e-06	9.93e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.21e-06	9.14e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CREBBP—esophageal cancer	4.61e-06	8.08e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CREBBP—esophageal cancer	4.5e-06	7.88e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—esophageal cancer	4.19e-06	7.35e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—esophageal cancer	4.13e-06	7.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—esophageal cancer	4.03e-06	7.06e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—esophageal cancer	3.77e-06	6.61e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—esophageal cancer	3.68e-06	6.46e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—EP300—esophageal cancer	3.14e-06	5.5e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—EP300—esophageal cancer	3.06e-06	5.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—esophageal cancer	2.32e-06	4.07e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.27e-06	3.97e-05	CbGpPWpGaD
